Peptides derived from the dependence receptor ALK are proapoptotic for ALK-positive tumors.

about

Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma

P2860

Q36586479-A54982D8-B784-4DA6-8113-9350A4BD664E

P2860

Peptides derived from the dependence receptor ALK are proapoptotic for ALK-positive tumors.

Item

http://www.wikidata.org/entity/Q38878195

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Peptides derived from the depe ...... totic for ALK-positive tumors.

@en

type

Item

label

Peptides derived from the depe ...... totic for ALK-positive tumors.

@en

prefLabel

Peptides derived from the depe ...... totic for ALK-positive tumors.

@en

P1476

Peptides derived from the depe ...... totic for ALK-positive tumors.

@en

P2093

A Aubry

http://www.w3.org/2001/XMLSchema#string

B Monsarrat

http://www.w3.org/2001/XMLSchema#string

C Marchand

http://www.w3.org/2001/XMLSchema#string

C Tricoire

http://www.w3.org/2001/XMLSchema#string

F Lopez

http://www.w3.org/2001/XMLSchema#string

F Malecaze

http://www.w3.org/2001/XMLSchema#string

L Ceccato

http://www.w3.org/2001/XMLSchema#string

M Allouche

http://www.w3.org/2001/XMLSchema#string

S Galiacy

http://www.w3.org/2001/XMLSchema#string

P2860

MYRbase: analysis of genome-wide glycine myristoylation enlarges the functional spectrum of eukaryotic myristoylated proteins

Anaplastic lymphoma kinase: signalling in development and disease

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation

Netrin-1 acts as a survival factor for aggressive neuroblastoma

Mechanisms of drug resistance in kinases.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.

EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.

The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers

P304

e1736

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDDIS.2015.102

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rod Bremner

C Racaud-Sultan

P577

2015-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276063707

http://www.w3.org/2001/XMLSchema#string

P698

25950466

http://www.w3.org/2001/XMLSchema#string

P932

4669685

http://www.w3.org/2001/XMLSchema#string

Peptides derived from the dependence receptor ALK are proapoptotic for ALK-positive tumors.

about

P2860

P2860

Peptides derived from the dependence receptor ALK are proapoptotic for ALK-positive tumors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932